Expert Ratings for Akoya Biosciences
Portfolio Pulse from Benzinga Insights
Akoya Biosciences (NASDAQ:AKYA) has received analyst ratings within the last quarter, with 1 bullish, 3 somewhat bullish, and no indifferent, somewhat bearish, or bearish ratings. The average 12-month price target among 4 analysts is $8.75, with a high of $11.00 and a low of $7.00. This target has decreased by 36.36% from the previous target of $13.75. Analysts typically review stocks quarterly or after major company updates, considering financial performance and company risks.
November 13, 2023 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Akoya Biosciences has a mix of bullish and somewhat bullish ratings from analysts, with an average price target of $8.75, which is a significant decrease from the previous target.
The decrease in the average price target suggests that analysts have become more cautious about the company's future performance, which could lead to a negative short-term impact on the stock price. The ratings are mixed but lean towards bullish, indicating some positive sentiment, yet the significant drop in the target price is likely to weigh more heavily on investor perceptions in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100